SPTXSeaport Therapeutics, Inc.
$18.14
$18.14
$15.2552 weeks$27.92
SPTX in its own filings
Nothing in SPTX's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
5
Events found in the filings · across 55 filings · the record starts in 2026
- Hard flags
- none
Hard flags
- Most recent filing
- Aug 3, 2026
Most recent filing · Form 10-Q
- Record starts
- May 4, 2026
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filinga quarter after the last one
- expected around Nov 2, 2026
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 3, 2026Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress.Earnings release · press release
- Jun 8, 2026Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress.Earnings release · press release
- May 4, 2026Amendments to Articles of Incorporation or Bylaws As previously disclosed in the Registration Statement on Form S-1, as amended (File No. 333-294976) (the “Registration Statement”) of Seaport Therapeutics, Inc. (the “Company”) and in connection with the consummation of the initial public offering of the Company’s …Charter/bylaw amendment or fiscal-year change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Biotechnology
The closest names by size in the same industry